Kabra Drugs Ltd

524322

Summary

Fair Value Assessment
Fair Value Not Available.
Fair ValueQUncertainty
Close Price10.56Feb 27, 2025
Market Closed
10.56
Price Down by |%
Previous Close
10.56
Day Range
10.56 – 10.56
Year Range
6.85 – 10.56
Bid / Ask
Market Cap
250.4 Mil
Volume / Average
400.0 / 1.9 k
Beta (5-Year)
-0.62
Shares Outstanding
23.71 Mil
Primary Exchange
Bombay Stock Exchange

Business Description
Kabra Drugs Ltd is an India-based drug manufacturing company. It is engaged in the business of Permaculture manufacturing and trading in pharma related products. Geographically, all the company operations are carried out in India. The company's drug manufacturing plant is located in Madhya Pradesh, India. Its products include Cardiovascular Drugs, Anti-Infective Drugs, Oncology Drugs, Gastroenterologic Drugs, Hormonal Drugs, etc.
Contact
No. 3, Swaminathan Street 2nd Floor, Chennai, TN 600 033
T +91 9884624100
www.kabradrugs.com opens in a new tab
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Most Recent Earnings
Dec 31, 2024
Fiscal Year End
Mar 31, 2025
Employees
31

Key Metrics

Income Statement (in Mil, except ratios)
12/31/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Revenue
Revenue Growth %
Gross Profit
Gross Profit Margin %
Operating Income
-18.41 -7.28 -3.44 -1.83 -1.80 -0.81
Operating Margin %
EBIT
-14.14 -7.29 -3.44 -1.85 -1.80 -0.81
EBIT Margin %
EBITDA
-14.14 -7.29 -3.44 -1.75 -1.49 -0.50
EBITDA Margin %
Net Income
-18.49 -7.36 -3.38 -1.85 -1.80 -0.60
Net Profit Margin %
Basic EPS
-2.30 -1.66 -0.77 -0.42 -0.41 -0.14
Diluted EPS
-2.30 -1.66 -0.77 -0.42 -0.41 -0.14
Normalized EPS
Total Dividends per Share
Balance Sheet (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Total Assets
49.54 45.72 7.04 7.30 14.02 14.15
Total Liabilities
16.73 34.89 14.35 11.23 16.10 14.43
Total Debt
6.40 17.08 13.82 10.26 9.00 6.52
Total Equity
32.81 10.83 -7.31 -3.93 -2.08 -0.28
Cash And Cash Equivalents
1.15 26.71 0.03 0.01 0.10 0.11
Working Capital
32.18 10.60 -7.54 -4.16 -2.41 -0.92
Shares Outstanding (Mil)
4.39 4.39 4.39
Book Value Per Share
2.47 -1.67 -0.90 -0.47 -0.06
Total Debt To Equity
0.20 1.58
Cash Flow Statement (in Mil, except ratios)
09/30/2024
03/2024
03/2023
03/2022
03/2021
03/2020
Cash From Operating Activities
-26.05 -2.09 -3.54 -1.34 -2.49 -0.46
Cash From Investing Activities
-0.40 0.63
Cash From Financing Activities
47.31 28.77 3.56 1.25 2.48 -0.17
Capital Expenditures
Free Cash Flow
-7.36 -3.38 -1.75 -1.49 -0.51
Change in Cash
20.86 26.68 0.02 -0.09 -0.01

Profile

There is no Key Executive Team data available.
Transaction History

Shares in Thousands
0 5 10 15 20 25 30 35 40
>
No Data Available
There is no available information for this investment.
Sep
2023
    • Buy
    • Acquisition
    • Option Exercise
    • Disposition
    • Sell
Transaction Detail
No Data Available
There is no available information for this investment.

Ownership

There is no Ownership data available.

© Copyright 2025 Morningstar, Inc. All rights reserved.
Terms of Use    Privacy Policy
© Copyright 2025 Morningstar, Inc. All rights reserved. Please read our Terms of Use above. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
As of December 1st, 2023, the ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar/Sustainalytics accepts no responsibility or liability whatsoever for the actions of third parties in this respect.
Company: Morningstar India Private Limited; Regd. Office: 9th floor, Platinum Technopark, Plot No. 17/18, Sector 30A, Vashi, Navi Mumbai – 400705, Maharashtra, India; CIN: U72300MH2004PTC245103; Telephone No.: +91-22-61217100; Fax No.: +91-22-61217200; Contact: Morningstar India Help Desk (e-mail: helpdesk.in@morningstar.com) in case of queries or grievances.
Top